Le Lézard
Classified in: Health
Subjects: PDT, MAT, MIN

NEEDED ANNOUNCES NEW BREAKTHROUGH SUPPLEMENT, SPERM SUPPORT+


With Studies Showing Male Sperm Counts Down 50+% Over the Last 50 Years, 
a Natural, Scientific Solution Offers Hope

LOS ANGELES, July 19, 2023 /PRNewswire/ -- Needed, the breakthrough nutritional supplement brand creating new standards for perinatal wellness, today announced the launch of Sperm Support+. This product will help men maximize their role in successful, healthy conception. Male fertility factors in 40-50% of fertility struggles, warranting a needed conversation around the shared role of both partners in pregnancy outcomes. Sperm Support+ addresses male fertility with an expertly formulated, whole-body approach using targeted antioxidants, probiotics, and testosterone-supporting botanicals to boost sperm quality, quantity, and motility.

Needed Sperm Support+ is a whole-body approach to supporting men's fertility, combining clinically-studied ingredients to address multiple factors, including sperm health, hormone levels, and microbiome balance. Unlike most male fertility products that only include basic vitamins in minimal doses, Needed includes targeted antioxidants that support cellular integrity and sperm viability, with 14 Billion CFU for gut and hormone health, and botanical blends, which have been used in traditional cultures for generations, and in recent research, have demonstrated the ability to positively impact sperm health.

"Sperm Support+ and the Needed Men's Fertility Plan are a must for couples trying to conceive to support the multiple components of fertility, including sperm health, gut health, optimal nutrient levels, and testosterone levels," says Dr. Stuart Fischbein, OBGYN. "There is compelling evidence that male fertility declines with age and lifestyle. I trust Needed products for my patient's as they use scientifically studied ingredients formulated with insights from practitioners who work with men's fertility every day."

"One-third of fertility challenges are caused specifically by sperm related issues that can be addressed and supported with proper nutrition, lifestyle and supplementation," said Needed Co-Founder Julie Sawaya. "Fertility is a men's and women's health issue, it takes collaboration to create the healthiest possible environment for the pregnancy outcomes you want. This is a new approach and a needed conversation."

Key ingredients and features of the Needed Sperm Support + include:

"Needed designs all of its products to work together in a system," shared co-founder Ryan Woodbury. "Sperm Support+ is designed to be taken with Needed's Men's Multi, Omega-3, and CoQ10 for the most comprehensive and effective approach to men's fertility."

Sperm Support+ is available starting at $40 and as part of the comprehensive Needed Men's Fertility Support Plan. Additional details can be found on www.thisisneeded.com.

Join the Needed Conversations on social @needed.

About Needed
Needed is the leading perinatal nutrition brand, backed by 4,000+ practitioners, from nutritionists to midwives to OB-GYNs. From conception to pregnancy to postpartum, Needed offers the most nutritionally complete, expertly crafted formulas backed by clinical research. Needed was founded in 2017 by two nutritionally-trained mothers, Julie Sawaya and Ryan Woodbury, to close the critical gap in perinatal nutrition and set a new science-backed health standard for women, their families, and our earth. Needed is a Certified B-Corp, 1% for the Planet member, and Climate Neutral-Certified. Learn more at thisisneeded.com.

SOURCE Needed


These press releases may also interest you

11 mai 2024
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

11 mai 2024
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

11 mai 2024
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

11 mai 2024
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

11 mai 2024
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

11 mai 2024
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...



News published on and distributed by: